Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: A prospective observational study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: To examine the first-trimester maternal serum placental growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) levels in pregnancies associated with pre-eclampsia (PE) or small-for-gestational-age (SGA) infants, and determine the predictive accuracy of PlGF and of PAPP-A for either PE or SGA infants. Methods: This prospective, observational study included 175 pregnant women, and of these women, due to participant withdrawal or loss to follow-up, delivery data were collected from the medical records of 155 women, including 4 who had twin pregnancies. The women’s maternal history was recorded, and the PlGF and PAPP-A levels at 11 to 13 gestational weeks were measured. During the second trimester, the maternal uterine artery’s systolic/diastolic ratio was measured. Multiples of the median (MoM) of PlGF and PAPP-A were determined, and the associations of these values with the risk factors of SGA and PE were evaluated. Logistic regression analysis was used to determine whether PlGF and PAPP-A are useful markers for predicting SGA infants. Results: The PAPP-A MoM level was significantly lower in women with advanced maternal age, multipara women, and women with gestational diabetes than in their counterparts. The PlGF and PAPP-A MoM levels were higher in women with a twin pregnancy than in those with a singleton pregnancy. There was a significant relationship between the maternal serum PAPP-A MoM level in the first trimester and the uterine artery systolic/diastolic ratio in the second trimester. Results: of logistic regression analysis showed that low PlGF and PAPP-A MoM levels were predictors of SGA infants (odds ratio, 0.143; 95% confidence interval, 0.025 to 0.806; odds ratio, 0.191; 95% confidence interval, 0.051 to 0.718, respectively). Conclusion: PlGF and PAPP-A are potentially useful as first-trimester markers for SGA infants and some hypertensive disorders of pregnancy.
Abstract
Objective: To examine the first-trimester maternal serum placental growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) levels in pregnancies associated with pre-eclampsia (PE) or small-for-gestational-age (SGA) infants, and determine the predictive accuracy of PlGF and of PAPP-A for either PE or SGA infants. Methods: This prospective, observational study included 175 pregnant women, and of these women, due to participant withdrawal or loss to follow-up, delivery data were collected from the medical records of 155 women, including 4 who had twin pregnancies. The women’s maternal history was recorded, and the PlGF and PAPP-A levels at 11 to 13 gestational weeks were measured. During the second trimester, the maternal uterine artery’s systolic/diastolic ratio was measured. Multiples of the median (MoM) of PlGF and PAPP-A were determined, and the associations of these values with the risk factors of SGA and PE were evaluated. Logistic regression analysis was used to determine whether PlGF and PAPP-A are useful markers for predicting SGA infants. Results: The PAPP-A MoM level was significantly lower in women with advanced maternal age, multipara women, and women with gestational diabetes than in their counterparts. The PlGF and PAPP-A MoM levels were higher in women with a twin pregnancy than in those with a singleton pregnancy. There was a significant relationship between the maternal serum PAPP-A MoM level in the first trimester and the uterine artery systolic/diastolic ratio in the second trimester. Results: of logistic regression analysis showed that low PlGF and PAPP-A MoM levels were predictors of SGA infants (odds ratio, 0.143; 95% confidence interval, 0.025 to 0.806; odds ratio, 0.191; 95% confidence interval, 0.051 to 0.718, respectively). Conclusion: PlGF and PAPP-A are potentially useful as first-trimester markers for SGA infants and some hypertensive disorders of pregnancy.
참고문헌 (39)
- Sibai BM, "National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about preeclampsia", Semin Perinatol, 27, pp.239~246 (2003)
- Hutcheon JA, "Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy", Best Pract Res Clin Obstet Gynaecol, 25, pp.391~403 (2011)
- Madazli R, "Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia", BJOG, 107, pp.514~518 (2000)
- Dekker G, "Primary, secondary, and tertiary prevention of pre-eclampsia", Lancet, 357, pp.209~215 (2001)
- Jackson MR, "Reduced placental villous tree elaboration in small-for-gestational-age pregnancies: relationship with umbilical artery Doppler waveforms", Am J Obstet Gynecol, 172, pp.518~525 (1995)
- Cowans NJ, "First-trimester placental growth factor as a marker for hypertensive disorders and SGA", Prenat Diagn, 30, pp.565~570 (2010)
- Poon LC, "Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation", Prenat Diagn, 28, pp.1110~1115 (2008)
- Kasdaglis T, "Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies", Ultrasound Obstet Gynecol, 35, pp.280~285 (2010)
- Torry DS, "Placenta growth factor: potential role in pregnancy", Am J Reprod Immunol, 41, pp.79~85 (1999)
- Maglione D, "Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor", Proc Natl Acad Sci U S A, 88, pp.9267~9271 (1991)
- Shore VH, "Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast", Placenta, 18, pp.657~665 (1997)
- Vuorela P, "Expression of vascular endothelial growth factor and placenta growth factor in human placenta", Biol Reprod, 56, pp.489~494 (1997)
- Brambati B, "Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A)in the first trimester in association with abnormal fetal karyotype", Br J Obstet Gynaecol, 100, pp.324~326 (1993)
- Yaron Y, "Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome", Prenat Diagn, 22, pp.778~782 (2002)
- Smith GC, "Early pregnancy levels of pregnancyassociated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth", J Clin Endocrinol Metab, 87, pp.1762~1767 (2002)
- Todros T, "Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction", Obstet Gynecol, 93, pp.499~503 (1999)
- Lounghna P, "Fetal sized and dating: charts recommended for clinical obstetric practice", Ultrasound, 17, pp.160~166 (2009)
- 이정주, "한국의 성별, 태아수별, 출산수별 임신주수에 따른 출생체중", Korean Journal of Pediatrics, 50(8), pp.732~739 (2007), 대한소아과학회
- Erez O, "The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age", J Matern Fetal Neonatal Med, 21, pp.279~287 (2008)
- Rana S, "Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia", Hypertension, 50, pp.137~142 (2007)
- Romero R, "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate", J Matern Fetal Neonatal Med, 21, pp.9~23 (2008)
- Weinstein L, "Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy", Am J Obstet Gynecol, 142, pp.159~167 (1982)
- Barker DJ, "Fetal nutrition and cardiovascular disease in adult life", Lancet, 341, pp.938~941 (1993)
- Sibai B, "Pre-eclampsia", Lancet, 365, pp.785~799 (2005)
- Curtin WM, "A review of HELLP syndrome", J Perinatol, 19, pp.138~143 (1999)
- Roberts JM, "Pathogenesis and genetics of pre-eclampsia", Lancet, 357, pp.53~56 (2001)
- Mihu D, "HELLP syndrome: a multisystemic disorder", J Gastrointestin Liver Dis, 16, pp.419~424 (2007)
- Sibai BM, "Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and", or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?, 2008, pp.199, 268~
- Vatten LJ, "Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia", Am J Obstet Gynecol, 196, pp.239~ (2007)
- Levine RJ, "Circulating angiogenic factors and the risk of preeclampsia", N Engl J Med, 350, pp.672~683 (2004)
- Thadhani R, "First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia", J Clin Endocrinol Metab, 89, pp.770~775 (2004)
- Tidwell SC, "Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia", Am J Obstet Gynecol, 184, pp.1267~1272 (2001)
- Smith GC, "Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth", Obstet Gynecol, 109, pp.1316~1324 (2007)
- Vatten LJ, "Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction", Acta Obstet Gynecol Scand, 91, pp.1388~1394 (2012)
- Ong CY, "First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications", BJOG, 107, pp.1265~1270 (2000)
- Sanchez O, "First trimester serum angiogenic", anti-angiogenic status in twin pregnancies:relationship with assisted reproduction technology, 2012, pp.27, 358~365
- Svirsky R, "First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy", Ultrasound Obstet Gynecol, 47, pp.560~564 (2016)
- Chasen ST, "Firsttrimester biochemistry and outcomes in twin pregnancy", J Reprod Med, 54, pp.312~314 (2009)
- Rochelson BL, "The clinical significance of Doppler umbilical artery velocimetry in the small for gestational age fetus", Am J Obstet Gynecol, 156, pp.1223~1226 (1987)